nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C9—Estropipate—osteoporosis	0.096	0.151	CbGbCtD
Candesartan—CYP2C8—Raloxifene—osteoporosis	0.0918	0.144	CbGbCtD
Candesartan—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0887	0.139	CbGbCtD
Candesartan—CYP2C8—Cholecalciferol—osteoporosis	0.0709	0.111	CbGbCtD
Candesartan—ABCB1—Ethinyl Estradiol—osteoporosis	0.06	0.0943	CbGbCtD
Candesartan—CYP2C8—Estradiol—osteoporosis	0.0571	0.0898	CbGbCtD
Candesartan—CYP2C9—Cholecalciferol—osteoporosis	0.0494	0.0777	CbGbCtD
Candesartan—ABCB1—Conjugated Estrogens—osteoporosis	0.0441	0.0692	CbGbCtD
Candesartan—CYP2C9—Estradiol—osteoporosis	0.0399	0.0626	CbGbCtD
Candesartan—ABCB1—Estradiol—osteoporosis	0.0387	0.0608	CbGbCtD
Candesartan—Pranlukast—TNF—osteoporosis	0.00273	0.708	CrCbGaD
Candesartan—Losartan—ACE—osteoporosis	0.00112	0.291	CrCbGaD
Candesartan—Arthralgia—Risedronate—osteoporosis	0.000602	0.0019	CcSEcCtD
Candesartan—Leukopenia—Pamidronate—osteoporosis	0.000601	0.0019	CcSEcCtD
Candesartan—Anxiety—Risedronate—osteoporosis	0.0006	0.0019	CcSEcCtD
Candesartan—Pruritus—Etidronic acid—osteoporosis	0.000597	0.00189	CcSEcCtD
Candesartan—Gastrointestinal pain—Estropipate—osteoporosis	0.000597	0.00189	CcSEcCtD
Candesartan—Acute coronary syndrome—Estradiol—osteoporosis	0.000597	0.00189	CcSEcCtD
Candesartan—Mental disorder—Conjugated Estrogens—osteoporosis	0.000595	0.00188	CcSEcCtD
Candesartan—Back pain—Zoledronate—osteoporosis	0.000594	0.00188	CcSEcCtD
Candesartan—Myocardial infarction—Estradiol—osteoporosis	0.000593	0.00187	CcSEcCtD
Candesartan—Malnutrition—Conjugated Estrogens—osteoporosis	0.000591	0.00187	CcSEcCtD
Candesartan—Gastrointestinal pain—Alendronate—osteoporosis	0.000588	0.00186	CcSEcCtD
Candesartan—Cough—Pamidronate—osteoporosis	0.000586	0.00185	CcSEcCtD
Candesartan—Hypertension—Pamidronate—osteoporosis	0.00058	0.00183	CcSEcCtD
Candesartan—Urticaria—Estropipate—osteoporosis	0.00058	0.00183	CcSEcCtD
Candesartan—Gastrointestinal pain—Raloxifene—osteoporosis	0.000578	0.00183	CcSEcCtD
Candesartan—Diarrhoea—Etidronic acid—osteoporosis	0.000577	0.00182	CcSEcCtD
Candesartan—Haematuria—Estradiol—osteoporosis	0.000577	0.00182	CcSEcCtD
Candesartan—Abdominal pain—Estropipate—osteoporosis	0.000577	0.00182	CcSEcCtD
Candesartan—Body temperature increased—Estropipate—osteoporosis	0.000577	0.00182	CcSEcCtD
Candesartan—Gastrointestinal pain—Ibandronate—osteoporosis	0.000572	0.00181	CcSEcCtD
Candesartan—Arthralgia—Pamidronate—osteoporosis	0.000572	0.00181	CcSEcCtD
Candesartan—Myalgia—Pamidronate—osteoporosis	0.000572	0.00181	CcSEcCtD
Candesartan—Back pain—Conjugated Estrogens—osteoporosis	0.000572	0.00181	CcSEcCtD
Candesartan—Urticaria—Alendronate—osteoporosis	0.000571	0.0018	CcSEcCtD
Candesartan—Epistaxis—Estradiol—osteoporosis	0.000571	0.0018	CcSEcCtD
Candesartan—Anxiety—Pamidronate—osteoporosis	0.00057	0.0018	CcSEcCtD
Candesartan—Abdominal pain—Alendronate—osteoporosis	0.000568	0.0018	CcSEcCtD
Candesartan—Body temperature increased—Alendronate—osteoporosis	0.000568	0.0018	CcSEcCtD
Candesartan—Sinusitis—Estradiol—osteoporosis	0.000568	0.00179	CcSEcCtD
Candesartan—Anaemia—Zoledronate—osteoporosis	0.000567	0.00179	CcSEcCtD
Candesartan—Angioedema—Zoledronate—osteoporosis	0.000561	0.00177	CcSEcCtD
Candesartan—Gastrointestinal pain—Calcitriol—osteoporosis	0.00056	0.00177	CcSEcCtD
Candesartan—Abdominal pain—Raloxifene—osteoporosis	0.000559	0.00177	CcSEcCtD
Candesartan—Body temperature increased—Raloxifene—osteoporosis	0.000559	0.00177	CcSEcCtD
Candesartan—Urticaria—Ibandronate—osteoporosis	0.000556	0.00176	CcSEcCtD
Candesartan—Body temperature increased—Ibandronate—osteoporosis	0.000553	0.00175	CcSEcCtD
Candesartan—Abdominal pain—Ibandronate—osteoporosis	0.000553	0.00175	CcSEcCtD
Candesartan—Vertigo—Zoledronate—osteoporosis	0.000551	0.00174	CcSEcCtD
Candesartan—Leukopenia—Zoledronate—osteoporosis	0.000549	0.00174	CcSEcCtD
Candesartan—Haemoglobin—Estradiol—osteoporosis	0.000546	0.00173	CcSEcCtD
Candesartan—Rhinitis—Estradiol—osteoporosis	0.000545	0.00172	CcSEcCtD
Candesartan—Urticaria—Calcitriol—osteoporosis	0.000544	0.00172	CcSEcCtD
Candesartan—Haemorrhage—Estradiol—osteoporosis	0.000543	0.00172	CcSEcCtD
Candesartan—Hepatitis—Estradiol—osteoporosis	0.000543	0.00172	CcSEcCtD
Candesartan—Palpitations—Zoledronate—osteoporosis	0.000542	0.00171	CcSEcCtD
Candesartan—Abdominal pain—Calcitriol—osteoporosis	0.000542	0.00171	CcSEcCtD
Candesartan—Body temperature increased—Calcitriol—osteoporosis	0.000542	0.00171	CcSEcCtD
Candesartan—Angioedema—Conjugated Estrogens—osteoporosis	0.00054	0.00171	CcSEcCtD
Candesartan—Pharyngitis—Estradiol—osteoporosis	0.000539	0.0017	CcSEcCtD
Candesartan—Thrombocytopenia—Pamidronate—osteoporosis	0.000537	0.0017	CcSEcCtD
Candesartan—Urinary tract disorder—Estradiol—osteoporosis	0.000537	0.0017	CcSEcCtD
Candesartan—Vomiting—Etidronic acid—osteoporosis	0.000536	0.0017	CcSEcCtD
Candesartan—Cough—Zoledronate—osteoporosis	0.000536	0.00169	CcSEcCtD
Candesartan—Oedema peripheral—Estradiol—osteoporosis	0.000535	0.00169	CcSEcCtD
Candesartan—Tachycardia—Pamidronate—osteoporosis	0.000535	0.00169	CcSEcCtD
Candesartan—Urethral disorder—Estradiol—osteoporosis	0.000533	0.00168	CcSEcCtD
Candesartan—Rash—Etidronic acid—osteoporosis	0.000532	0.00168	CcSEcCtD
Candesartan—Dermatitis—Etidronic acid—osteoporosis	0.000532	0.00168	CcSEcCtD
Candesartan—Vertigo—Conjugated Estrogens—osteoporosis	0.000531	0.00168	CcSEcCtD
Candesartan—Hyperhidrosis—Pamidronate—osteoporosis	0.00053	0.00168	CcSEcCtD
Candesartan—Hypertension—Zoledronate—osteoporosis	0.00053	0.00167	CcSEcCtD
Candesartan—Headache—Etidronic acid—osteoporosis	0.000529	0.00167	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000526	0.00166	CcSEcCtD
Candesartan—Asthenia—Estropipate—osteoporosis	0.000524	0.00166	CcSEcCtD
Candesartan—Arthralgia—Zoledronate—osteoporosis	0.000523	0.00165	CcSEcCtD
Candesartan—Chest pain—Zoledronate—osteoporosis	0.000523	0.00165	CcSEcCtD
Candesartan—Myalgia—Zoledronate—osteoporosis	0.000523	0.00165	CcSEcCtD
Candesartan—Palpitations—Conjugated Estrogens—osteoporosis	0.000522	0.00165	CcSEcCtD
Candesartan—Anxiety—Zoledronate—osteoporosis	0.000521	0.00165	CcSEcCtD
Candesartan—Paraesthesia—Risedronate—osteoporosis	0.000518	0.00164	CcSEcCtD
Candesartan—Pruritus—Estropipate—osteoporosis	0.000516	0.00163	CcSEcCtD
Candesartan—Asthenia—Alendronate—osteoporosis	0.000516	0.00163	CcSEcCtD
Candesartan—Cough—Conjugated Estrogens—osteoporosis	0.000516	0.00163	CcSEcCtD
Candesartan—Dyspnoea—Risedronate—osteoporosis	0.000514	0.00163	CcSEcCtD
Candesartan—Hypotension—Pamidronate—osteoporosis	0.000512	0.00162	CcSEcCtD
Candesartan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000511	0.00161	CcSEcCtD
Candesartan—Fatigue—Ethinyl Estradiol—osteoporosis	0.00051	0.00161	CcSEcCtD
Candesartan—Pruritus—Alendronate—osteoporosis	0.000509	0.00161	CcSEcCtD
Candesartan—Dyspepsia—Risedronate—osteoporosis	0.000508	0.0016	CcSEcCtD
Candesartan—Chest pain—Conjugated Estrogens—osteoporosis	0.000503	0.00159	CcSEcCtD
Candesartan—Myalgia—Conjugated Estrogens—osteoporosis	0.000503	0.00159	CcSEcCtD
Candesartan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000503	0.00159	CcSEcCtD
Candesartan—Asthenia—Ibandronate—osteoporosis	0.000502	0.00159	CcSEcCtD
Candesartan—Anxiety—Conjugated Estrogens—osteoporosis	0.000501	0.00158	CcSEcCtD
Candesartan—Nausea—Etidronic acid—osteoporosis	0.000501	0.00158	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.0005	0.00158	CcSEcCtD
Candesartan—Diarrhoea—Estropipate—osteoporosis	0.000499	0.00158	CcSEcCtD
Candesartan—Gastrointestinal disorder—Risedronate—osteoporosis	0.000498	0.00157	CcSEcCtD
Candesartan—Fatigue—Risedronate—osteoporosis	0.000497	0.00157	CcSEcCtD
Candesartan—Pruritus—Ibandronate—osteoporosis	0.000495	0.00157	CcSEcCtD
Candesartan—Paraesthesia—Pamidronate—osteoporosis	0.000492	0.00156	CcSEcCtD
Candesartan—Diarrhoea—Alendronate—osteoporosis	0.000492	0.00155	CcSEcCtD
Candesartan—Asthenia—Calcitriol—osteoporosis	0.000492	0.00155	CcSEcCtD
Candesartan—Thrombocytopenia—Zoledronate—osteoporosis	0.00049	0.00155	CcSEcCtD
Candesartan—Dyspnoea—Pamidronate—osteoporosis	0.000489	0.00155	CcSEcCtD
Candesartan—Tachycardia—Zoledronate—osteoporosis	0.000489	0.00154	CcSEcCtD
Candesartan—Somnolence—Pamidronate—osteoporosis	0.000488	0.00154	CcSEcCtD
Candesartan—Pruritus—Calcitriol—osteoporosis	0.000485	0.00153	CcSEcCtD
Candesartan—Hyperhidrosis—Zoledronate—osteoporosis	0.000484	0.00153	CcSEcCtD
Candesartan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000484	0.00153	CcSEcCtD
Candesartan—Diarrhoea—Raloxifene—osteoporosis	0.000484	0.00153	CcSEcCtD
Candesartan—Dyspepsia—Pamidronate—osteoporosis	0.000483	0.00153	CcSEcCtD
Candesartan—Dizziness—Estropipate—osteoporosis	0.000483	0.00153	CcSEcCtD
Candesartan—Diarrhoea—Ibandronate—osteoporosis	0.000479	0.00151	CcSEcCtD
Candesartan—Mental disorder—Estradiol—osteoporosis	0.000476	0.0015	CcSEcCtD
Candesartan—Dizziness—Alendronate—osteoporosis	0.000475	0.0015	CcSEcCtD
Candesartan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000473	0.0015	CcSEcCtD
Candesartan—Malnutrition—Estradiol—osteoporosis	0.000473	0.00149	CcSEcCtD
Candesartan—Fatigue—Pamidronate—osteoporosis	0.000473	0.00149	CcSEcCtD
Candesartan—Gastrointestinal pain—Risedronate—osteoporosis	0.000472	0.00149	CcSEcCtD
Candesartan—Tachycardia—Conjugated Estrogens—osteoporosis	0.000471	0.00149	CcSEcCtD
Candesartan—Urticaria—Ethinyl Estradiol—osteoporosis	0.00047	0.00149	CcSEcCtD
Candesartan—Diarrhoea—Calcitriol—osteoporosis	0.000469	0.00148	CcSEcCtD
Candesartan—Hypotension—Zoledronate—osteoporosis	0.000468	0.00148	CcSEcCtD
Candesartan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000468	0.00148	CcSEcCtD
Candesartan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000468	0.00148	CcSEcCtD
Candesartan—Dizziness—Raloxifene—osteoporosis	0.000468	0.00148	CcSEcCtD
Candesartan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000466	0.00147	CcSEcCtD
Candesartan—Vomiting—Estropipate—osteoporosis	0.000464	0.00147	CcSEcCtD
Candesartan—Dizziness—Ibandronate—osteoporosis	0.000463	0.00146	CcSEcCtD
Candesartan—Rash—Estropipate—osteoporosis	0.00046	0.00145	CcSEcCtD
Candesartan—Dermatitis—Estropipate—osteoporosis	0.00046	0.00145	CcSEcCtD
Candesartan—Urticaria—Risedronate—osteoporosis	0.000458	0.00145	CcSEcCtD
Candesartan—Back pain—Estradiol—osteoporosis	0.000458	0.00145	CcSEcCtD
Candesartan—Headache—Estropipate—osteoporosis	0.000457	0.00145	CcSEcCtD
Candesartan—Vomiting—Alendronate—osteoporosis	0.000457	0.00144	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000456	0.00144	CcSEcCtD
Candesartan—Abdominal pain—Risedronate—osteoporosis	0.000456	0.00144	CcSEcCtD
Candesartan—Body temperature increased—Risedronate—osteoporosis	0.000456	0.00144	CcSEcCtD
Candesartan—Rash—Alendronate—osteoporosis	0.000453	0.00143	CcSEcCtD
Candesartan—Dermatitis—Alendronate—osteoporosis	0.000453	0.00143	CcSEcCtD
Candesartan—Hypotension—Conjugated Estrogens—osteoporosis	0.000451	0.00142	CcSEcCtD
Candesartan—Headache—Alendronate—osteoporosis	0.00045	0.00142	CcSEcCtD
Candesartan—Paraesthesia—Zoledronate—osteoporosis	0.00045	0.00142	CcSEcCtD
Candesartan—Vomiting—Raloxifene—osteoporosis	0.00045	0.00142	CcSEcCtD
Candesartan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000448	0.00142	CcSEcCtD
Candesartan—Dyspnoea—Zoledronate—osteoporosis	0.000447	0.00141	CcSEcCtD
Candesartan—Rash—Raloxifene—osteoporosis	0.000446	0.00141	CcSEcCtD
Candesartan—Dermatitis—Raloxifene—osteoporosis	0.000445	0.00141	CcSEcCtD
Candesartan—Somnolence—Zoledronate—osteoporosis	0.000445	0.00141	CcSEcCtD
Candesartan—Vomiting—Ibandronate—osteoporosis	0.000445	0.00141	CcSEcCtD
Candesartan—Headache—Raloxifene—osteoporosis	0.000443	0.0014	CcSEcCtD
Candesartan—Rash—Ibandronate—osteoporosis	0.000441	0.00139	CcSEcCtD
Candesartan—Dermatitis—Ibandronate—osteoporosis	0.000441	0.00139	CcSEcCtD
Candesartan—Dyspepsia—Zoledronate—osteoporosis	0.000441	0.00139	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000439	0.00139	CcSEcCtD
Candesartan—Headache—Ibandronate—osteoporosis	0.000439	0.00139	CcSEcCtD
Candesartan—Vomiting—Calcitriol—osteoporosis	0.000436	0.00138	CcSEcCtD
Candesartan—Nausea—Estropipate—osteoporosis	0.000434	0.00137	CcSEcCtD
Candesartan—Abdominal pain—Pamidronate—osteoporosis	0.000434	0.00137	CcSEcCtD
Candesartan—Body temperature increased—Pamidronate—osteoporosis	0.000434	0.00137	CcSEcCtD
Candesartan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000433	0.00137	CcSEcCtD
Candesartan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000432	0.00137	CcSEcCtD
Candesartan—Angioedema—Estradiol—osteoporosis	0.000432	0.00137	CcSEcCtD
Candesartan—Rash—Calcitriol—osteoporosis	0.000432	0.00137	CcSEcCtD
Candesartan—Fatigue—Zoledronate—osteoporosis	0.000432	0.00136	CcSEcCtD
Candesartan—Dermatitis—Calcitriol—osteoporosis	0.000432	0.00136	CcSEcCtD
Candesartan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00043	0.00136	CcSEcCtD
Candesartan—Headache—Calcitriol—osteoporosis	0.000429	0.00136	CcSEcCtD
Candesartan—Somnolence—Conjugated Estrogens—osteoporosis	0.000429	0.00136	CcSEcCtD
Candesartan—Nausea—Alendronate—osteoporosis	0.000427	0.00135	CcSEcCtD
Candesartan—Vertigo—Estradiol—osteoporosis	0.000425	0.00134	CcSEcCtD
Candesartan—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000425	0.00134	CcSEcCtD
Candesartan—Asthenia—Ethinyl Estradiol—osteoporosis	0.000425	0.00134	CcSEcCtD
Candesartan—Nausea—Raloxifene—osteoporosis	0.00042	0.00133	CcSEcCtD
Candesartan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000419	0.00132	CcSEcCtD
Candesartan—Palpitations—Estradiol—osteoporosis	0.000418	0.00132	CcSEcCtD
Candesartan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000416	0.00132	CcSEcCtD
Candesartan—Fatigue—Conjugated Estrogens—osteoporosis	0.000416	0.00131	CcSEcCtD
Candesartan—Nausea—Ibandronate—osteoporosis	0.000416	0.00131	CcSEcCtD
Candesartan—Asthenia—Risedronate—osteoporosis	0.000414	0.00131	CcSEcCtD
Candesartan—Cough—Estradiol—osteoporosis	0.000413	0.0013	CcSEcCtD
Candesartan—Gastrointestinal pain—Zoledronate—osteoporosis	0.00041	0.00129	CcSEcCtD
Candesartan—Hypertension—Estradiol—osteoporosis	0.000408	0.00129	CcSEcCtD
Candesartan—Pruritus—Risedronate—osteoporosis	0.000408	0.00129	CcSEcCtD
Candesartan—Nausea—Calcitriol—osteoporosis	0.000407	0.00129	CcSEcCtD
Candesartan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000405	0.00128	CcSEcCtD
Candesartan—Arthralgia—Estradiol—osteoporosis	0.000403	0.00127	CcSEcCtD
Candesartan—Chest pain—Estradiol—osteoporosis	0.000403	0.00127	CcSEcCtD
Candesartan—Myalgia—Estradiol—osteoporosis	0.000403	0.00127	CcSEcCtD
Candesartan—Anxiety—Estradiol—osteoporosis	0.000401	0.00127	CcSEcCtD
Candesartan—Urticaria—Zoledronate—osteoporosis	0.000398	0.00126	CcSEcCtD
Candesartan—Abdominal pain—Zoledronate—osteoporosis	0.000396	0.00125	CcSEcCtD
Candesartan—Body temperature increased—Zoledronate—osteoporosis	0.000396	0.00125	CcSEcCtD
Candesartan—Diarrhoea—Risedronate—osteoporosis	0.000395	0.00125	CcSEcCtD
Candesartan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000394	0.00125	CcSEcCtD
Candesartan—Asthenia—Pamidronate—osteoporosis	0.000393	0.00124	CcSEcCtD
Candesartan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000391	0.00124	CcSEcCtD
Candesartan—Pruritus—Pamidronate—osteoporosis	0.000388	0.00123	CcSEcCtD
Candesartan—Urticaria—Conjugated Estrogens—osteoporosis	0.000383	0.00121	CcSEcCtD
Candesartan—Dizziness—Risedronate—osteoporosis	0.000381	0.00121	CcSEcCtD
Candesartan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000381	0.0012	CcSEcCtD
Candesartan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000381	0.0012	CcSEcCtD
Candesartan—Tachycardia—Estradiol—osteoporosis	0.000377	0.00119	CcSEcCtD
Candesartan—Vomiting—Ethinyl Estradiol—osteoporosis	0.000376	0.00119	CcSEcCtD
Candesartan—Diarrhoea—Pamidronate—osteoporosis	0.000375	0.00119	CcSEcCtD
Candesartan—Hyperhidrosis—Estradiol—osteoporosis	0.000373	0.00118	CcSEcCtD
Candesartan—Rash—Ethinyl Estradiol—osteoporosis	0.000373	0.00118	CcSEcCtD
Candesartan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000373	0.00118	CcSEcCtD
Candesartan—Headache—Ethinyl Estradiol—osteoporosis	0.000371	0.00117	CcSEcCtD
Candesartan—Vomiting—Risedronate—osteoporosis	0.000367	0.00116	CcSEcCtD
Candesartan—Rash—Risedronate—osteoporosis	0.000364	0.00115	CcSEcCtD
Candesartan—Dermatitis—Risedronate—osteoporosis	0.000363	0.00115	CcSEcCtD
Candesartan—Dizziness—Pamidronate—osteoporosis	0.000363	0.00115	CcSEcCtD
Candesartan—Headache—Risedronate—osteoporosis	0.000361	0.00114	CcSEcCtD
Candesartan—Asthenia—Zoledronate—osteoporosis	0.000359	0.00114	CcSEcCtD
Candesartan—Pruritus—Zoledronate—osteoporosis	0.000354	0.00112	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000352	0.00111	CcSEcCtD
Candesartan—Nausea—Ethinyl Estradiol—osteoporosis	0.000351	0.00111	CcSEcCtD
Candesartan—Vomiting—Pamidronate—osteoporosis	0.000349	0.0011	CcSEcCtD
Candesartan—Paraesthesia—Estradiol—osteoporosis	0.000347	0.0011	CcSEcCtD
Candesartan—Asthenia—Conjugated Estrogens—osteoporosis	0.000346	0.00109	CcSEcCtD
Candesartan—Rash—Pamidronate—osteoporosis	0.000346	0.00109	CcSEcCtD
Candesartan—Dermatitis—Pamidronate—osteoporosis	0.000345	0.00109	CcSEcCtD
Candesartan—Dyspnoea—Estradiol—osteoporosis	0.000344	0.00109	CcSEcCtD
Candesartan—Headache—Pamidronate—osteoporosis	0.000344	0.00109	CcSEcCtD
Candesartan—Somnolence—Estradiol—osteoporosis	0.000343	0.00108	CcSEcCtD
Candesartan—Diarrhoea—Zoledronate—osteoporosis	0.000343	0.00108	CcSEcCtD
Candesartan—Nausea—Risedronate—osteoporosis	0.000343	0.00108	CcSEcCtD
Candesartan—Pruritus—Conjugated Estrogens—osteoporosis	0.000341	0.00108	CcSEcCtD
Candesartan—Dyspepsia—Estradiol—osteoporosis	0.00034	0.00107	CcSEcCtD
Candesartan—Gastrointestinal disorder—Estradiol—osteoporosis	0.000333	0.00105	CcSEcCtD
Candesartan—Fatigue—Estradiol—osteoporosis	0.000333	0.00105	CcSEcCtD
Candesartan—Dizziness—Zoledronate—osteoporosis	0.000331	0.00105	CcSEcCtD
Candesartan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00033	0.00104	CcSEcCtD
Candesartan—Nausea—Pamidronate—osteoporosis	0.000326	0.00103	CcSEcCtD
Candesartan—Dizziness—Conjugated Estrogens—osteoporosis	0.000319	0.00101	CcSEcCtD
Candesartan—Vomiting—Zoledronate—osteoporosis	0.000318	0.00101	CcSEcCtD
Candesartan—Rash—Zoledronate—osteoporosis	0.000316	0.000998	CcSEcCtD
Candesartan—Gastrointestinal pain—Estradiol—osteoporosis	0.000316	0.000998	CcSEcCtD
Candesartan—Dermatitis—Zoledronate—osteoporosis	0.000316	0.000997	CcSEcCtD
Candesartan—Headache—Zoledronate—osteoporosis	0.000314	0.000992	CcSEcCtD
Candesartan—Vomiting—Conjugated Estrogens—osteoporosis	0.000307	0.000969	CcSEcCtD
Candesartan—Urticaria—Estradiol—osteoporosis	0.000307	0.000969	CcSEcCtD
Candesartan—Body temperature increased—Estradiol—osteoporosis	0.000305	0.000964	CcSEcCtD
Candesartan—Abdominal pain—Estradiol—osteoporosis	0.000305	0.000964	CcSEcCtD
Candesartan—Rash—Conjugated Estrogens—osteoporosis	0.000304	0.000961	CcSEcCtD
Candesartan—Dermatitis—Conjugated Estrogens—osteoporosis	0.000304	0.00096	CcSEcCtD
Candesartan—Headache—Conjugated Estrogens—osteoporosis	0.000302	0.000955	CcSEcCtD
Candesartan—Nausea—Zoledronate—osteoporosis	0.000298	0.00094	CcSEcCtD
Candesartan—Nausea—Conjugated Estrogens—osteoporosis	0.000286	0.000905	CcSEcCtD
Candesartan—Asthenia—Estradiol—osteoporosis	0.000277	0.000875	CcSEcCtD
Candesartan—Pruritus—Estradiol—osteoporosis	0.000273	0.000863	CcSEcCtD
Candesartan—Diarrhoea—Estradiol—osteoporosis	0.000264	0.000835	CcSEcCtD
Candesartan—Dizziness—Estradiol—osteoporosis	0.000255	0.000807	CcSEcCtD
Candesartan—Vomiting—Estradiol—osteoporosis	0.000245	0.000776	CcSEcCtD
Candesartan—Rash—Estradiol—osteoporosis	0.000243	0.000769	CcSEcCtD
Candesartan—Dermatitis—Estradiol—osteoporosis	0.000243	0.000768	CcSEcCtD
Candesartan—Headache—Estradiol—osteoporosis	0.000242	0.000764	CcSEcCtD
Candesartan—Nausea—Estradiol—osteoporosis	0.000229	0.000725	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—WNT1—osteoporosis	0.000194	0.00448	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000191	0.00441	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000189	0.00437	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—TGFB1—osteoporosis	0.000184	0.00425	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—CYP27A1—osteoporosis	0.000182	0.00422	CbGpPWpGaD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000181	0.00419	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—MGLL—osteoporosis	0.000181	0.00418	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00018	0.00417	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP27A1—osteoporosis	0.00018	0.00416	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000179	0.00414	CbGpPWpGaD
Candesartan—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000179	0.00413	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—PTHLH—osteoporosis	0.000175	0.00405	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—TNF—osteoporosis	0.000172	0.00397	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	0.000171	0.00395	CbGpPWpGaD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000168	0.00388	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MGLL—osteoporosis	0.000164	0.00379	CbGpPWpGaD
Candesartan—UGT1A3—Biological oxidations—POMC—osteoporosis	0.000158	0.00366	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—POMC—osteoporosis	0.000158	0.00365	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CALCA—osteoporosis	0.000154	0.00356	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PKM—osteoporosis	0.000149	0.00345	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—FDPS—osteoporosis	0.000149	0.00345	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.000149	0.00343	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—CYP19A1—osteoporosis	0.000148	0.00343	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000147	0.00339	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000146	0.00339	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PGLS—osteoporosis	0.000142	0.00327	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GPD2—osteoporosis	0.000142	0.00327	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.00014	0.00323	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000139	0.00322	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000136	0.00314	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SOST—osteoporosis	0.000135	0.00312	CbGpPWpGaD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000134	0.00309	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PNP—osteoporosis	0.000129	0.00299	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ATIC—osteoporosis	0.000129	0.00299	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000126	0.00291	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000122	0.00282	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CALCR—osteoporosis	0.000122	0.00282	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTH1R—osteoporosis	0.000122	0.00282	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PTH—osteoporosis	0.000119	0.00276	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000119	0.00275	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CNR2—osteoporosis	0.000116	0.00269	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000116	0.00267	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	0.000113	0.00262	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CA2—osteoporosis	0.00011	0.00254	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—OXCT1—osteoporosis	0.00011	0.00254	CbGpPWpGaD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000109	0.00252	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000108	0.00251	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PTH—osteoporosis	0.000108	0.00251	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000108	0.00251	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—MGLL—osteoporosis	0.000107	0.00248	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000106	0.00245	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CNR2—osteoporosis	0.000106	0.00244	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—TGFB1—osteoporosis	0.000104	0.00241	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—WNT1—osteoporosis	9.94e-05	0.0023	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.93e-05	0.0023	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PTHLH—osteoporosis	9.9e-05	0.00229	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MGLL—osteoporosis	9.69e-05	0.00224	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	9.59e-05	0.00222	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LRP5—osteoporosis	9.46e-05	0.00219	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	9.45e-05	0.00219	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.41e-05	0.00218	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.22e-05	0.00213	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—IDH2—osteoporosis	9.12e-05	0.00211	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LRP6—osteoporosis	9.05e-05	0.00209	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.99e-05	0.00208	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PTHLH—osteoporosis	8.99e-05	0.00208	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—POMC—osteoporosis	8.92e-05	0.00206	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.83e-05	0.00204	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8.77e-05	0.00203	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CALCA—osteoporosis	8.71e-05	0.00201	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP27A1—osteoporosis	8.58e-05	0.00198	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	8.46e-05	0.00195	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PKM—osteoporosis	8.41e-05	0.00194	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—FDPS—osteoporosis	8.41e-05	0.00194	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ACP5—osteoporosis	8.34e-05	0.00193	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	8.21e-05	0.0019	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—POMC—osteoporosis	8.07e-05	0.00186	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPD2—osteoporosis	7.97e-05	0.00184	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PGLS—osteoporosis	7.97e-05	0.00184	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	7.92e-05	0.00183	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CALCA—osteoporosis	7.91e-05	0.00183	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	7.8e-05	0.0018	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—TPI1—osteoporosis	7.76e-05	0.00179	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	7.69e-05	0.00178	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TLN1—osteoporosis	7.64e-05	0.00177	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.32e-05	0.00169	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—P4HB—osteoporosis	7.29e-05	0.00169	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PNP—osteoporosis	7.29e-05	0.00169	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ATIC—osteoporosis	7.29e-05	0.00169	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GAPDH—osteoporosis	7.16e-05	0.00165	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.13e-05	0.00165	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.01e-05	0.00162	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—RAP1A—osteoporosis	6.97e-05	0.00161	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL1B—osteoporosis	6.94e-05	0.0016	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.64e-05	0.00154	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	6.62e-05	0.00153	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—P4HB—osteoporosis	6.59e-05	0.00152	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTH—osteoporosis	6.41e-05	0.00148	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RAP1A—osteoporosis	6.3e-05	0.00146	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CNR2—osteoporosis	6.24e-05	0.00144	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	6.22e-05	0.00144	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CA2—osteoporosis	6.2e-05	0.00143	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—OXCT1—osteoporosis	6.2e-05	0.00143	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—ADCY5—osteoporosis	6.2e-05	0.00143	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFATC1—osteoporosis	6.14e-05	0.00142	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—DKK1—osteoporosis	6.09e-05	0.00141	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MGLL—osteoporosis	6.04e-05	0.0014	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.96e-05	0.00138	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—WNT1—osteoporosis	5.87e-05	0.00136	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—POMC—osteoporosis	5.76e-05	0.00133	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGA—osteoporosis	5.71e-05	0.00132	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.7e-05	0.00132	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.7e-05	0.00132	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ENO1—osteoporosis	5.64e-05	0.0013	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—ADCY5—osteoporosis	5.63e-05	0.0013	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PSMA2—osteoporosis	5.55e-05	0.00128	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PSMA5—osteoporosis	5.55e-05	0.00128	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—FDPS—osteoporosis	5.43e-05	0.00126	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PKM—osteoporosis	5.43e-05	0.00126	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TGFB1—osteoporosis	5.39e-05	0.00125	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTHLH—osteoporosis	5.31e-05	0.00123	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BMP2—osteoporosis	5.31e-05	0.00123	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGB—osteoporosis	5.2e-05	0.0012	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPD2—osteoporosis	5.15e-05	0.00119	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PGLS—osteoporosis	5.15e-05	0.00119	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—IDH2—osteoporosis	5.14e-05	0.00119	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.13e-05	0.00119	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—osteoporosis	5.04e-05	0.00116	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PSMA2—osteoporosis	5.02e-05	0.00116	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PSMA5—osteoporosis	5.02e-05	0.00116	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.85e-05	0.00112	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP27A1—osteoporosis	4.83e-05	0.00112	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—FDPS—osteoporosis	4.73e-05	0.00109	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PKM—osteoporosis	4.73e-05	0.00109	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ATIC—osteoporosis	4.71e-05	0.00109	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PNP—osteoporosis	4.71e-05	0.00109	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ACP5—osteoporosis	4.7e-05	0.00109	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—POMC—osteoporosis	4.69e-05	0.00108	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CALCA—osteoporosis	4.67e-05	0.00108	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.64e-05	0.00107	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—POMC—osteoporosis	4.56e-05	0.00105	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP19A1—osteoporosis	4.51e-05	0.00104	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PGLS—osteoporosis	4.49e-05	0.00104	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPD2—osteoporosis	4.49e-05	0.00104	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	4.44e-05	0.00103	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—FDPS—osteoporosis	4.42e-05	0.00102	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PKM—osteoporosis	4.42e-05	0.00102	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TPI1—osteoporosis	4.37e-05	0.00101	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KL—osteoporosis	4.24e-05	0.000981	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PGLS—osteoporosis	4.19e-05	0.000969	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPD2—osteoporosis	4.19e-05	0.000969	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—POMC—osteoporosis	4.14e-05	0.000957	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—P4HB—osteoporosis	4.11e-05	0.00095	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PNP—osteoporosis	4.1e-05	0.000949	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ATIC—osteoporosis	4.1e-05	0.000949	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6R—osteoporosis	4.04e-05	0.000933	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GAPDH—osteoporosis	4.03e-05	0.000932	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CA2—osteoporosis	4.01e-05	0.000926	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—OXCT1—osteoporosis	4.01e-05	0.000926	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—RAP1A—osteoporosis	3.93e-05	0.000908	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MGLL—osteoporosis	3.9e-05	0.000902	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PNP—osteoporosis	3.83e-05	0.000886	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ATIC—osteoporosis	3.83e-05	0.000886	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ADCY5—osteoporosis	3.68e-05	0.000851	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.68e-05	0.000851	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GPX1—osteoporosis	3.67e-05	0.000848	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CA2—osteoporosis	3.49e-05	0.000807	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—OXCT1—osteoporosis	3.49e-05	0.000807	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.42e-05	0.000792	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MGLL—osteoporosis	3.4e-05	0.000786	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—MTHFR—osteoporosis	3.39e-05	0.000783	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ADCY5—osteoporosis	3.32e-05	0.000768	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—IDH2—osteoporosis	3.32e-05	0.000767	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—OXCT1—osteoporosis	3.26e-05	0.000754	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CA2—osteoporosis	3.26e-05	0.000754	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SPP1—osteoporosis	3.22e-05	0.000743	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MGLL—osteoporosis	3.18e-05	0.000734	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ENO1—osteoporosis	3.17e-05	0.000734	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PSMA5—osteoporosis	3.13e-05	0.000723	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PSMA2—osteoporosis	3.13e-05	0.000723	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP27A1—osteoporosis	3.12e-05	0.000721	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ACP5—osteoporosis	3.04e-05	0.000702	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3e-05	0.000693	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3e-05	0.000692	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IRS2—osteoporosis	2.91e-05	0.000672	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—IDH2—osteoporosis	2.89e-05	0.000668	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LEP—osteoporosis	2.85e-05	0.000658	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TPI1—osteoporosis	2.82e-05	0.000652	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP27A1—osteoporosis	2.72e-05	0.000628	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ESR1—osteoporosis	2.72e-05	0.000628	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—POMC—osteoporosis	2.71e-05	0.000626	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—IDH2—osteoporosis	2.7e-05	0.000624	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.67e-05	0.000617	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.66e-05	0.000615	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—P4HB—osteoporosis	2.65e-05	0.000613	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ACP5—osteoporosis	2.64e-05	0.000611	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GAPDH—osteoporosis	2.6e-05	0.000602	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.54e-05	0.000587	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IRS1—osteoporosis	2.54e-05	0.000587	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP19A1—osteoporosis	2.54e-05	0.000587	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—RAP1A—osteoporosis	2.54e-05	0.000586	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.49e-05	0.000576	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.49e-05	0.000574	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ACP5—osteoporosis	2.47e-05	0.000571	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TPI1—osteoporosis	2.46e-05	0.000568	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—POMC—osteoporosis	2.45e-05	0.000565	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.44e-05	0.000564	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6R—osteoporosis	2.39e-05	0.000551	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1—osteoporosis	2.35e-05	0.000544	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—P4HB—osteoporosis	2.31e-05	0.000534	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TPI1—osteoporosis	2.3e-05	0.000531	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GAPDH—osteoporosis	2.27e-05	0.000524	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.21e-05	0.000511	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—RAP1A—osteoporosis	2.21e-05	0.000511	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—P4HB—osteoporosis	2.16e-05	0.000499	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GAPDH—osteoporosis	2.12e-05	0.00049	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ADCY5—osteoporosis	2.07e-05	0.000479	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPX1—osteoporosis	2.07e-05	0.000478	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—RAP1A—osteoporosis	2.06e-05	0.000477	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ENO1—osteoporosis	2.05e-05	0.000474	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PSMA2—osteoporosis	2.02e-05	0.000467	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PSMA5—osteoporosis	2.02e-05	0.000467	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—osteoporosis	1.91e-05	0.000441	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.8e-05	0.000416	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—osteoporosis	1.8e-05	0.000416	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ENO1—osteoporosis	1.79e-05	0.000413	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PSMA2—osteoporosis	1.76e-05	0.000407	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PSMA5—osteoporosis	1.76e-05	0.000407	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ENO1—osteoporosis	1.67e-05	0.000386	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PSMA2—osteoporosis	1.64e-05	0.00038	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PSMA5—osteoporosis	1.64e-05	0.00038	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.64e-05	0.000379	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—POMC—osteoporosis	1.53e-05	0.000353	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP19A1—osteoporosis	1.43e-05	0.00033	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—osteoporosis	1.41e-05	0.000327	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—osteoporosis	1.41e-05	0.000326	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ADCY5—osteoporosis	1.34e-05	0.00031	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPX1—osteoporosis	1.33e-05	0.000309	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.33e-05	0.000308	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—osteoporosis	1.23e-05	0.000285	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ADCY5—osteoporosis	1.17e-05	0.00027	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX1—osteoporosis	1.16e-05	0.000269	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ADCY5—osteoporosis	1.09e-05	0.000252	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX1—osteoporosis	1.09e-05	0.000251	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—osteoporosis	1.07e-05	0.000248	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—osteoporosis	1.06e-05	0.000246	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—osteoporosis	1e-05	0.000232	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—POMC—osteoporosis	9.85e-06	0.000228	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—POMC—osteoporosis	8.58e-06	0.000198	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—POMC—osteoporosis	8.02e-06	0.000185	CbGpPWpGaD
